Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia (Q82718676)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

H Yagasaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Y Takahashi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A Hama

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

K Kudo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

N Nishio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

H Muramatsu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Tanaka

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

N Yoshida

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

K Matsumoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

N Watanabe

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

K Kato

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

K Horibe

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S Kojima

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1508-1513

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118992%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2009.378

17 January 2020

exact match

0 references

cites work

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Current status of allogeneic bone marrow transplantation in acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Allogeneic stem cell transplantation for aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021

Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.378

7 January 2021